Comparison of the efficacy and safety of selective COX-2 inhibitors and non-steroidal anti-inflammatory drugs in the treatment of COVID-19 patients: a systematic review and network meta-analysis.

BMC Infect Dis · 2026 · PMC13032441 · PMID 41723349

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

However, the difference did not reach statistical significance, which still suggests that COX-2 inhibitors may have a potential advantage in terms of safety (Table 2 , eFig. 2 C and 3 C).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.